Mono- Versus Polyubiquitination: Differential Control of p53 Fate by Mdm2
The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
Although Mdm2-mediated ubiquitination is essential for both degradation and nuclear export of p53, the molecular basis for the differential effects of Mdm2 remains unknown. Here we show that low levels of Mdm2 activity induce monoubiquitination and nuclear export of p53, whereas high levels promote p53's polyubiquitination and nuclear degradation. A p53-ubiquitin fusion protein that mimics monoubiquitinated p53 was found to accumulate in the cytoplasm in an Mdm2-independent manner, indicating that monoubiquitination is critical for p53 trafficking. These results clarify the nature of ubiquitination-mediated p53 regulation and suggest that distinct mechanisms regulate p53 function in accordance with the levels of Mdm2 activity.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“proteasome inhibition by ALLN stabilizes p53 mainly in the nucleus of RKO cancer cells, whereas cytoplasmic p53 accumulates to a far lower extent”
From Stress-mediated nuclear stabilization of p53 is regulated by ubiquitination and importin-α3 binding (2010) · cites this paper as [23]
In the citing paper
“Interestingly, although p53 nuclear import is negatively regulated by ubiquitin modification, p53 nuclear export as well as translocation of cytoplasmic p53 to mitochondria are positively regulated by ubiquitin.23,37,38”
From Stress-mediated nuclear stabilization of p53 is regulated by ubiquitination and importin-α3 binding (2010) · cites this paper as [23]
In the citing paper
“Interestingly, although p53 nuclear import is negatively regulated by ubiquitin modification, p53 nuclear export as well as translocation of cytoplasmic p53 to mitochondria are positively regulated by ubiquitin.23,37,38”
From Stress-mediated nuclear stabilization of p53 is regulated by ubiquitination and importin-α3 binding (2010) · cites this paper as [23]
In the citing paper
“Additionally, mono-ubiquitination of p53 can facilitate export of p53 from the nucleus to the cytoplasm, thereby inhibiting its role as a transcription factor [110,111].”
From The p53 orchestra: Mdm2 and Mdmx set the tone (2010) · cites this paper as [111]
In the citing paper
“However, proteasome-dependent degradation of nuclear p53 can also effectively prevent its transactivation function [111,112], suggesting monoubiquitylation of cytoplasmic p53 is required for other processes.”
From The p53 orchestra: Mdm2 and Mdmx set the tone (2010) · cites this paper as [111]
Citations
Cites
Vogelstein, B., Lane, D., & Levine, A. J. (2000) · Nature · doi:10.1038/35042675 · Cited by 6,607
Mdm2 promotes the rapid degradation of p53
Haupt, Y., Maya, R., Kazaz, A., & Oren, M. (1997) · Nature · doi:10.1038/387296a0 · Cited by 4,506
Regulation of p53 stability by Mdm2
Kubbutat, M. H. G., Jones, S. N., & Vousden, K. H. (1997) · Nature · doi:10.1038/387299a0 · Cited by 3,312
Mechanisms Underlying Ubiquitination
Pickart, C. M. (2001) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.70.1.503 · Cited by 3,184
Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53
Honda, R., Tanaka, H., & Yasuda, H. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)01480-4 · Cited by 1,951
Mdm2 Is a RING Finger-dependent Ubiquitin Protein Ligase for Itself and p53
Fang, S., Jensen, J. P., Ludwig, R. L., Vousden, K. H., & Weissman, A. M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.12.8945 · Cited by 1,044
Deubiquitination of p53 by HAUSP is an important pathway for p53 stabilization
Li, M., Chen, D., Shiloh, A., Luo, J., Nikolaev, A. Y., Qin, J., & Gu, W. (2002) · Nature · doi:10.1038/nature737 · Cited by 1,031
Self-citationStommel, J. M., Marchenko, N. D., Jimenez, G. S., Moll, U. M., Hope, T. J., & Wahl, G. M. (1999) · The EMBO Journal · doi:10.1093/emboj/18.6.1660 · Cited by 738
Pirh2, a p53-Induced Ubiquitin-Protein Ligase, Promotes p53 Degradation
Leng, R. P., Lin, Y., Ma, W., Wu, H., Lemmers, B., Chung, S., Parant, J. M., Lozano, G., Hakem, R., & Benchimol, S. (2003) · Cell · doi:10.1016/s0092-8674(03)00193-4 · Cited by 722
Generation of oscillations by the p53-Mdm2 feedback loop: A theoretical and experimental study
Lev Bar-Or, R., Maya, R., Segel, L. A., Alon, U., Levine, A. J., & Oren, M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.210171597 · Cited by 588
Cited by
Items 401–500 of 797
CARPs enhance p53 turnover by degrading 14-3-3σ and stabilizing MDM2
Yang, W., Dicker, D. T., Chen, J., & El‐Deiry, W. S. (2008) · Cell Cycle · doi:10.4161/cc.7.5.5701 · Cited by 40
Gao, C., Chen, G., Romero, G. G., Moschos, S. J., Xu, X. M., & Hu, J. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.532606 · Cited by 40
Regulation of mitochondrial apoptosis by Pin1 in cancer and neurodegeneration
Sorrentino, G., Comel, A., Mantovani, F., & Sal, G. D. (2014) · Mitochondrion · doi:10.1016/j.mito.2014.08.003 · Cited by 39
Negative auto-regulators trap p53 in their web
Zhou, X., Cao, B., & Lu, H. (2017) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjx001 · Cited by 36
Li, W., Peng, X., Lang, J., & Xu, C. S. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00631 · Cited by 39
“Low levels of MDM2 activity lead to p53 monoubiquitination and nuclear export whereas high levels promote p53 polyubiquitination and nuclear degradation (Li et al., 2003).”
BackgroundSrc phosphorylation converts Mdm2 from a ubiquitinating to a neddylating E3 ligase
Batuello, C. N., Hauck, P. M., Gendron, J. M., Lehman, J. A., & Mayo, L. D. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1416656112 · Cited by 38
“In fact, ectopic expression that leads to high levels of Mdm2 has been reported to facilitate polyubiquitination of p53 (19).”
BackgroundShmueli, A., & Oren, M. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.03.006 · Cited by 37
The p53-Mdm2 Loop: A Critical Juncture of Stress Response
Levav-Cohen, Y., Goldberg, Z., Tan, K. H., Alsheich-Bartok, O., Zuckerman, V., Haupt, S., & Haupt, Y. (2014) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-94-017-9211-0_9 · Cited by 42
“It was found, that when expressed in low levels, Mdm2 can mediate p53monoubiquitination, which signals for p53 nuclear export and leads to its accumulation in the cytoplasm, thereby inhibiting its role as transcription factor [72, 73].”
BackgroundThe Fanconi anemia ID2 complex: Dueling saxes at the crossroads
Boisvert, R. A., & Howlett, N. G. (2014) · Cell Cycle · doi:10.4161/15384101.2014.956475 · Cited by 42
“Conversely, when levels of MDM2 are high, p53 is predominantly polyubiquitinated.(84) Likewise, it is plausible that the cellular concentration of FANCL is sufficient for FANCD2/I monoubiquitination only, precluding further ubiquitination.”
BackgroundBattle Against Cancer: An Everlasting Saga of p53
Hao, Q., & Cho, W. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms151222109 · Cited by 48
“degradation [23–25]; and prompts nuclear export of p53 by inducing its mono-ubiquitination [26].”
BackgroundKim, D.-H., Kim, E.-H., Na, H.-K., Sun, Y., & Surh, Y.-J. (2010) · Oncogene · doi:10.1038/onc.2010.8 · Cited by 36
MdmX regulates transformation and chromosomal stability in p53-deficient cells
Matijasevic, Z., Krzywicka-Racka, A., Sluder, G., & Jones, S. N. (2008) · Cell Cycle · doi:10.4161/cc.7.19.6797 · Cited by 34
E3 ubiquitin ligase Cullin4B mediated polyubiquitination of p53 for its degradation
Anand, T., Singh, P., Govindarajalu, G., Bandi, V., & Baluchamy, S. (2014) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-014-1960-3 · Cited by 37
“Other types of ubiquitination which includes mono- or K63-linked polyubiquitination can lead to nuclear export and cytosolic localizations resulting in p53 stabilization [32, 40].”
BackgroundUras, I. Z., List, T., & Nijman, S. M. B. (2012) · PLoS ONE · doi:10.1371/journal.pone.0031003 · Cited by 32
“Furthermore, mono-ubiquitination of tyrosine kinase receptors triggers receptor endocytosis and p53 mono-ubiquitination stimulates its nuclear export [40,41].”
BackgroundSpatial and temporal roles of SARS‐CoV PL pro —A snapshot
Yan, S., & Wu, G. (2020) · The FASEB Journal · doi:10.1096/fj.202002271 · Cited by 45
Liu, X., Xu, B., Yang, J., He, L., Zhang, Z., Cheng, X. L., Yu, H., Liu, X., Jin, T. Y., Peng, Y., et al. (2021) · Molecular Cell · doi:10.1016/j.molcel.2021.05.022 · Cited by 37
“In vivo and in vitro ubiquitination assay In vivo ubiquitination assay was performed as previously described (Li et al., 2003) with subtle modifications.”
MethodKarni-Schmidt, O., Zupnick, A., Castillo, M., Ahmed, A., Matos, T., Bouvet, P., Cordon‐Cardo, C., & Prives, C. L. (2008) · Journal of Cell Science · doi:10.1242/jcs.030098 · Cited by 40
“Multiple groups have reported that Mdm2-E3 ligase activity is crucial for both nuclear export and degradation of p53 (Boyd et al., 2000; Geyer et al., 2000; Haupt et al., 1997; Honda et al., 1997; Lohrum et al., 2001).”
BackgroundLu, Y., Amleh, A., Sun, J., Jin, X. S., McCullough, S. D., Baer, R. J., Ren, D., Li, R., & Hu, Y. (2006) · Molecular Endocrinology · doi:10.1210/me.2006-0188 · Cited by 37
“Cotransfection with a mutant ubiquitin (KO), in which all lysine residues in ubiquitin were mutated to arginine (34), resulted in a diminished signal for the Ni-NTA-agarose-bound species (lanes 11 and 12; top panel of Fig.”
BackgroundSelf-citationMirzaei, H., Rogers, R. S., Grimes, B., Eng, J. K., Aderem, A. A., & Aebersold, R. H. (2010) · Molecular BioSystems · doi:10.1039/c005242f · Cited by 35
Cytoplasmic tethering is involved in synergistic inhibition of p53 by Mdmx and Mdm2
Ohtsubo, C., Shiokawa, D., Kodama, M., Gaiddon, C., Nakagama, H., Jochemsen, A. G., Taya, Y., & Okamoto, K. (2009) · Cancer Science · doi:10.1111/j.1349-7006.2009.01180.x · Cited by 32
Tian, X., Liu, F., Zhang, X. P., Li, J., & Wang, W. (2012) · PLoS ONE · doi:10.1371/journal.pone.0038164 · Cited by 35
Live Cell Imaging of Protein Dislocation from the Endoplasmic Reticulum
Zhong, Y., & Fang, S. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.381798 · Cited by 37
Zhang, Z., He, G., Lv, Y., Liu, Y., Niu, Z., Feng, Q., Hu, R., & Xu, J. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-04511-7 · Cited by 35
Saha, T., Vardhini, D., Tang, Y., Katuri, V., Jogunoori, W. S., Volpe, E., Haines, D., Sidawy, A. N., Zhou, X., Gallicano, G. I., et al. (2005) · Oncogene · doi:10.1038/sj.onc.1209123 · Cited by 33
“The best-known example of this type of modification is ubiquitination (Li et al., 2003).”
BackgroundWang, Y. E., Pernet, O., & Lee, B. (2011) · Biology of the Cell · doi:10.1111/boc.201100105 · Cited by 37
“As discussed in the section ‘Ub and nuclear import/export,’ p53 nuclear export depends on monoubiquitination on Cterminal lysine residues (Lohrum et al., 2001; Li et al., 2003).”
BackgroundInfluentialStochastic Modeling and Simulation of the p53-MDM2/MDMX Loop
Cai, X., & Yuan, Z.-M. (2009) · Journal of Computational Biology · doi:10.1089/cmb.2008.0231 · Cited by 34
“Low levels of MDM2 induce mono-ubiquitination and nuclear export of p53, whereas high levels promote its polyubiquitination and nuclear degradation (Li et al., 2003).”
Comparative Genomics and Protein Domain Graph Analyses Link Ubiquitination and RNA Metabolism
Lucas‐Lledó, J. I., Arnau, V., & Marín, I. (2006) · Journal of Molecular Biology · doi:10.1016/j.jmb.2005.12.068 · Cited by 33
p19 Interacts with and Activates p73 by Involving the MDM2 Protein
Jeong, M.-H., Bae, J., Kim, W., Yoo, S.-M., Kim, J.-W., Song, P. I., & Choi, K. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m513853200 · Cited by 35
Overton, J. D., & Leibel, R. L. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.224592 · Cited by 34
Kim, C. K., Lee, S. B., Nguyen, T. L. X., Lee, K.-H., Um, S. H., Kim, J., & Ahn, J. (2011) · Experimental Cell Research · doi:10.1016/j.yexcr.2011.08.013 · Cited by 34
“HDM2 is often present at high levels in tumors with wild type p53 and promotes polyubiquitination and nuclear degradation of p53 [10–14], while a low level of HDM2 induces monoubiquitination and nuclear export of p53 [13].”
BackgroundRegulation of p53 Level by UBE4B in Breast Cancer
Zhang, Y., Lv, Y., Zhang, Y., & Gao, H. (2014) · PLoS ONE · doi:10.1371/journal.pone.0090154 · Cited by 32
UBE4B targets phosphorylated p53 at serines 15 and 392 for degradation
Du, C., Wu, H., & Leng, R. P. (2015) · Oncotarget · doi:10.18632/oncotarget.6555 · Cited by 32
Zhong, Y., Wang, Y., Yang, H., Ballar, P., Lee, J., Ye, Y., Monteiro, M. J., & Fang, S. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.272906 · Cited by 31
Illuzzi, J. L., Vickers, C. A., & Kmiec, E. B. (2011) · Journal of Molecular Neuroscience · doi:10.1007/s12031-011-9516-4 · Cited by 35
Vaziri, S. A. J., Hill, J. E., Chikamori, K., Grabowski, D., Takigawa, N., Chawla‐Sarkar, M., Rybicki, L., Gudkov, A. V., Mekhail, T. M., Bukowski, R. M., et al. (2005) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0222 · Cited by 33
He, Y., Huang, J., Wang, P., Shen, X., Li, S., Yang, L., Liu, W., Suksamrarn, A., Zhang, G., & Wang, F. (2015) · Oncotarget · doi:10.18632/oncotarget.6616 · Cited by 34
“Therefore, inhibition of the 26S proteasome by emodin may increase the stability of p53 and thus increase its pro-apoptotic effect, as observed for other proteasome inhibitors [43].”
BackgroundKatz, C., Low-Calle, A. M., Choe, J. H., Laptenko, O., Tong, D., Joseph-Chowdhury, J.-S. N., Garofalo, F., Zhu, Y. Y., Friedler, A., & Prives, C. L. (2018) · Genes & Development · doi:10.1101/gad.304071.117 · Cited by 34
“While seemingly at odds with the prior assumption that p53 monoubiquitination is required for its nuclear export (Li et al. 2003), it was reported that the function of mono-ubiquitination is to expose the NES within a p53 tetramer (Carter et al. 2007).”
Hurst-Kennedy, J., Zhong, M., Gupta, V., et al. (2010) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2010.05.010 · Cited by 31
Faust, T. B., Li, Y., Jang, G. Μ., Johnson, J. R., Yang, S., Weiss, A., Krogan, N. J., & Frankel, A. D. (2017) · Scientific Reports · doi:10.1038/srep45394 · Cited by 35
PTPRO-mediated autophagy prevents hepatosteatosis and tumorigenesis
Zhang, W., Hou, J., Wang, X., Jiang, R., Yin, Y., Ji, J., Deng, L., Huang, X., Wang, K., & Sun, B. (2015) · Oncotarget · doi:10.18632/oncotarget.3353 · Cited by 34
“As previously shown, low levels of Mdm2 activity induce mono-ubiquitination and nuclear export of p53, whereas high levels promote poly-ubiquitination of p53 and nuclear degradation [47, 48].”
BackgroundMono-ubiquitination Drives Nuclear Export of the Human DCN1-like Protein hDCNL1
Wu, K., Yan, H., Fang, L., Wang, X., Pfleger, C. M., Jiang, X., Huang, L., & Pan, Z. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.273045 · Cited by 31
Chen, S., Wang, D.-L., Liu, Y., Zhao, L., & Sun, F.-L. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.05966-11 · Cited by 35
“It has been shown that the ubiquitination of p53 acts as a signal for its cytoplasmic translocation (37, 66).”
BackgroundPEPD is a pivotal regulator of p53 tumor suppressor
Yang, L., Li, Y., Bhattacharya, A., & Zhang, Y. (2017) · Nature Communications · doi:10.1038/s41467-017-02097-9 · Cited by 29
Constrained α-Helical Peptides as Inhibitors of Protein-Protein and Protein-DNA Interactions
Roy, S., Ghosh, P., Ahmed, I., Chakraborty, M., Naiya, G., & Ghosh, B. (2018) · Biomedicines · doi:10.3390/biomedicines6040118 · Cited by 35
“Also, MDM2 is responsible for ubiquitination and proteasomal degradation of the p53 protein [77].”
BackgroundHIV-1 Tat Recruits HDM2 E3 Ligase To Target IRF-1 for Ubiquitination and Proteasomal Degradation
Remoli, A. L., Marsili, G., Perrotti, E., Acchioni, C., Sgarbanti, M., Borsetti, A., Hiscott, J. B., & Battistini, A. (2016) · mBio · doi:10.1128/mbio.01528-16 · Cited by 33
Regulation of E3 ubiquitin ligases by homotypic and heterotypic assembly
Balaji, V., & Hoppe, T. (2020) · F1000Research · doi:10.12688/f1000research.21253.1 · Cited by 36
p53: a molecular marker for the detection of cancer
Boyd, M. T., & Vlatković, N. (2008) · Expert Opinion on Medical Diagnostics · doi:10.1517/17530059.2.9.1013 · Cited by 33
“MDM2 targets p53 for ubiquitylation, leading to export of p53 from the nucleus and/or degradation by proteasomes [66,67] .”
HOPS/TMUB1 retains p53 in the cytoplasm and sustains p53‐dependent mitochondrial apoptosis
Castelli, M., Piobbico, D., Chiacchiaretta, M., Brunacci, C., Pieroni, S., Bartoli, D., Gargaro, M., Fallarino, F., Puccetti, P., Soddu, S., et al. (2019) · EMBO Reports · doi:10.15252/embr.201948073 · Cited by 30
“This assay was performed as previously described [55].”
Mdm2 links genotoxic stress and metabolism to p53
Wang, Z., & Li, B. (2010) · Protein & Cell · doi:10.1007/s13238-010-0140-9 · Cited by 32
“Ubiquitinated p53 exists in two forms, monoubiquitination, which might elicit nuclear export of p53, and polyubiquitination, which promotes proteasomal degradation of p53 (Li et al., 2003).”
BackgroundBimodal regulation of the PRC2 complex by USP7 underlies tumorigenesis
Su, D., Wang, W., Hou, Y., Wang, L., Yi, X., Cao, C., Wang, Y., Gao, H. F., Wang, Y., Yang, C., et al. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkab209 · Cited by 34
Monoubiquitination of EEA1 regulates endosome fusion and trafficking
Ramanathan, H. N., Zhang, G., & Ye, Y. (2013) · Cell & Bioscience · doi:10.1186/2045-3701-3-24 · Cited by 34
“To understand the functional consequence of EEA1 monoubiquitination, we took advantage of the observation that in-frame fusion of ubiquitin to a protein often mimics endogenously generated mono-ubiquitinated protein [24,25].”
BackgroundUSP9X destabilizes pVHL and promotes cell proliferation
Zhang, C., Peng, Z., Zhu, M., Wang, P., Du, X., Li, X., Liu, Y., Jin, Y., McNutt, M. A., & Yin, Y. (2016) · Oncotarget · doi:10.18632/oncotarget.11139 · Cited by 30
“In vivo ubiquitination assays were performed as previously described [71].”
MethodG Protein Mono-ubiquitination by the Rsp5 Ubiquitin Ligase
Torres, M. P., Lee, M. J., Ding, F., Purbeck, C., Kuhlman, B. A., Dokholyan, N. V., & Dohlman, H. G. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m809058200 · Cited by 29
Functional analysis of p53 tumor suppressor in yeast
Šmardová, J., Šmarda, J., & Koptíková, J. (2005) · Differentiation · doi:10.1111/j.1432-0436.2005.00028.x · Cited by 41
It Takes 15 to Tango: Making Sense of the Many Ubiquitin Ligases of p53
Love, I. M., & Grossman, S. R. (2012) · Genes & Cancer · doi:10.1177/1947601912455198 · Cited by 32
“The importance of understanding the regulation of p53 mono- and polyubiquitination is highlighted by the starkly contrasting activities of mono- versus polyubiquitinated p53: Several studies support the notion that monoubiquitinated p53 is exported to the cytoplasm, where most polyubiquitination seems to occur.(10,129…”
BackgroundTimmerman, D. M., Remmers, T. L., Hillenius, S., & Looijenga, L. H. J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22105377 · Cited by 28
Deregulation of cyclin E meets dysfunction in p53: Closing the escape hatch on breast cancer
Barton, M. C., Akli, S., & Keyomarsi, K. (2006) · Journal of Cellular Physiology · doi:10.1002/jcp.20818 · Cited by 30
“…its export to the cytoplasm without poly-ubiquitylation and proteosomal degradation; while, high levels of Mdm2 protein, induced by activated p53 in response to stress, promote the degradation process within the nucleus and terminate stress response (Li et al., 2003; Brooks and Gu, 2006).”
BackgroundKeePin’ the p53 Family in Good Shape
Mantovani, F., Gostissa, M., Collavin, L., & Sal, G. D. (2004) · Cell Cycle · doi:10.4161/cc.3.7.999 · Cited by 32
Husaini, R., Ahmad, M., & Khoo, A. S. B. (2011) · BMC Research Notes · doi:10.1186/1756-0500-4-551 · Cited by 27
“This is in concordance with the findings that mono-ubiquitination acts as a signal for p53 nuclear export whereas poly-ubiquitinated p53 species are targeted for 26S proteosome degradation [31].”
Pan, M., & Blattner, C. (2021) · Cancers · doi:10.3390/cancers13040745 · Cited by 29
Interaction of p53 with prolyl isomerases: Healthy and unhealthy relationships
Mantovani, F., Zannini, A., Rustighi, A., & Sal, G. D. (2015) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2015.01.013 · Cited by 35
“p53 sub-cellular localization can be modulated by ubiquitination: while poly-ubiquitination causes proteasome-mediated degradation, monoubiquitination promotes its cytoplasmic localization [112,113].”
BackgroundRETRACTED: lncRNA TRMP-S directs dual mechanisms to regulate p27-mediated cellular senescence
Tian, S., Khan, M. R., Zhang, X. D., Li, J., Thorne, R. F., Wu, M., & Shao, F. (2021) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2021.04.004 · Cited by 30
RetractedPeng, T., Qiu, X., Tan, L., Yu, S., Yang, B., Dai, J., Liu, X., Sun, Y., Song, C., Liu, W., et al. (2021) · Journal of Virology · doi:10.1128/jvi.01629-21 · Cited by 29
“Monoubiquitin modifications have also been shown to regulate the nuclear-cytoplasmic trafficking of cellular proteins, including p53 (42), phosphatase and TENsin homolog (PTEN) (43), NF-kappa B (NF-kB), and NF-kB essential modulator (NEMO/IKKg) (44).”
BackgroundRoles of p53-Mediated Host–Virus Interaction in Coronavirus Infection
Wang, X., Liu, Y., Li, K., & Hao, Z. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24076371 · Cited by 34
“In normal physiological mammalian cells, p53 is maintained at low levels, usually by continued ubiquitination and subsequent degradation by murine double minute-2 (MDM2) [10,22,23].”
BackgroundWhen Ubiquitin Meets NF-κB: A Trove for Anti-cancer Drug Development
Wu, Z., & Shi, Y. (2013) · Current Pharmaceutical Design · doi:10.2174/1381612811319180010 · Cited by 28
“Similarly under genotoxic stress condition, low levels of Mdm2 can mediate monoubiquitination of p53 which leads to its nuclear export, thereby inhibiting overactivation of p53 in response to mild DNA damage [31].”
BackgroundHan, K.-J., Foster, D. G., Harhaj, E. W., Dzieciątkowska, M., Hansen, K. C., & Liu, C.-W. (2016) · Human Molecular Genetics · doi:10.1093/hmg/ddw021 · Cited by 26
Patrolling the nucleus: inner nuclear membrane-associated degradation
Smoyer, C. J., & Jaspersen, S. L. (2019) · Current Genetics · doi:10.1007/s00294-019-00971-1 · Cited by 27
Walters, M. S., Kyratsous, C. A., Wan, S., & Silverstein, S. J. (2008) · Journal of Virology · doi:10.1128/jvi.00685-08 · Cited by 27
Heat-shock protein 90 inhibitors in antineoplastic therapy: is it all wrapped up?
Isaacs, J. S. (2005) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.14.6.569 · Cited by 26
Transcription factors and cognate signalling cascades in the regulation of autophagy
Chandra, V., Bhagyaraj, E., Parkesh, R., & Gupta, P. (2016) · Biological Reviews · doi:10.1111/brv.12177 · Cited by 26
“Physiological abundance of p53 is maintained by E3 ubiquitin ligase mouse double minute 2 homolog (MDM2)-mediated ubiquitination and proteasomal degradation (Li et al., 2003; Nie, Sasaki & Maki, 2007).”
BackgroundImproving bioorthogonal protein ubiquitylation by click reaction
Schneider, D., Schneider, T., Rösner, D., Scheffner, M., & Marx, A. (2013) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2013.03.063 · Cited by 32
Adaptor proteins and ubiquinators in TGF-β signaling
Mishra, L., & Marshall, B. (2005) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2005.09.001 · Cited by 29
Skorta, I., Oren, M., Markwardt, C., Gutekunst, M., Aulitzky, W. E., & van der Kuip, H. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0548 · Cited by 24
Behind the scenes: Unravelling the molecular mechanisms of p53 target gene selectivity (Review)
Lohrum (2010) · International Journal of Oncology · doi:10.3892/ijo_00000757 · Cited by 30
“Whereas polyubiquitination is important for the p53 protein degradation, monoubiquitination of p53 by MDM2 results in nuclear export of p53 (32).”
BackgroundA Role for the Cyclin Box in the Ubiquitin-Mediated Degradation of Cyclin G1
Piscopo, D. M., & Hinds, P. W. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6346 · Cited by 28
Alternative UPS drug targets upstream the 26S proteasome
Hjerpe, R., & Rodríguez, M. S. (2007) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2007.11.021 · Cited by 28
E6AP in the Brain: One Protein, Dual Function, Multiple Diseases
Hokayem, J. A. E., & Nawaz, Z. (2013) · Molecular Neurobiology · doi:10.1007/s12035-013-8563-y · Cited by 32
“[26–28].”
Stallings, C. L., Duigou, G. J., Gershon, A. A., Gershon, M. D., & Silverstein, S. J. (2006) · Journal of Virology · doi:10.1128/jvi.80.3.1497-1512.2006 · Cited by 24
Smoyer, C. J., Smith, S. E., Gardner, J. M., McCroskey, S., Unruh, J. R., & Jaspersen, S. L. (2019) · Genetics · doi:10.1534/genetics.119.301911 · Cited by 23
Ubiquitin, SUMO, and Nedd8 as Therapeutic Targets in Cancer
Gâtel, P., Piechaczyk, M., & Bossis, G. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-38266-7_2 · Cited by 23
“Interestingly, MDM2 can also monoUbiquitylate p53, which entails nuclear export and, thereby, inhibition of transcriptional activity [74].”
BackgroundOverexpression of ligase defective E6-associated protein, E6-AP, results in mammary tumorigenesis
Ramamoorthy, S., Tufail, R., Hokayem, J. E., et al. (2011) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1567-2 · Cited by 23
“oncogenes and tumor are targets for degradation via the ubiquitin–proteasome pathway [30], suggesting that”
BackgroundBTK blocks the inhibitory effects of MDM2 on p53 activity
Rada, M., Althubiti, M., Ekpenyong‐Akiba, A. E., Lee, K.-G., Lam, K., Fedorova, O., Barlev, N. A., & Macip, S. (2017) · Oncotarget · doi:10.18632/oncotarget.22543 · Cited by 24
“The underlying mechanism is the nuclear export and proteasome-mediated degradation of the polyubiquitinated protein [16, 20].”
BackgroundThe roles of mouse double minute 2 (MDM2) oncoprotein in ocular diseases: A review
Jiang, H., Luo, J., & Lei, H. (2022) · Experimental Eye Research · doi:10.1016/j.exer.2021.108910 · Cited by 23
Phosphorylation of MdmX by CDK2/Cdc2p34 is required for nuclear export of Mdm2
Elias, B. C., Laine, A. M., & Ronai, Z. A. (2005) · Oncogene · doi:10.1038/sj.onc.1208488 · Cited by 28
Induction of endoreduplication by a JNK inhibitor SP600125 in human lung carcinoma A 549 cells
Yamasaki-Miyamoto, Y., Yamasaki, M., Tachibana, H., & Yamada, K. (2007) · Cell Biology International · doi:10.1016/j.cellbi.2007.07.002 · Cited by 28
Muscolini, M., Montagni, E., Palermo, V., Agostino, S. D., Gu, W., Abdelmoula-Souissi, S., Mazzoni, C., Blandino, G., & Tuosto, L. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.279539 · Cited by 27
Self-citationMedicinal Chemistry of Inhibiting RING-Type E3 Ubiquitin Ligases
Blaquière, N., Villemure, E., & Staben, S. T. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b01451 · Cited by 26
Genetic Influences in Breast Cancer Drug Resistance
Daniyal, A., Santoso, I., Gunawan, N. H. P., Barliana, M. I., & Abdulah, R. (2021) · Breast Cancer Targets and Therapy · doi:10.2147/bctt.s284453 · Cited by 28
Comparative Genomics Reveals Factors Associated with Phenotypic Expression of Wolbachia
Baião, G. C., Janice, J., Galinou, M., & Klasson, L. (2021) · Genome Biology and Evolution · doi:10.1093/gbe/evab111 · Cited by 23
Fungal Secondary Metabolites as Inhibitors of the Ubiquitin–Proteasome System
Staszczak, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222413309 · Cited by 23
Hochrainer, K., Racchumi, G., Zhang, S., Iadecola, C., & Anrather, J. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-011-0912-2 · Cited by 31
“This method was previously established to reveal the role of monoubiquitination in regulating p53 and FOXO4 transcriptional activities [33, 34].”
MethodInduction of Apoptosis in Jeko-1 Mantle Cell Lymphoma Cell Line by Resveratrol: A Proteomic Analysis
Cecconi, D., Zamò, A., Parisi, A., Bianchi, E., Parolini, C., Timperio, A. M., Zolla, L., & Chilosi, M. (2008) · Journal of Proteome Research · doi:10.1021/pr700712p · Cited by 24
E3 ubiquitin ligases and human papillomavirus-induced carcinogenesis
Lou, Z., & Wang, S. (2014) · Journal of International Medical Research · doi:10.1177/0300060513506655 · Cited by 22
“The effects of Mdm2 on p53 are concentration-dependent: low Mdm2 induces p53 monoubiquitination and nuclear export; high Mdm2 promotes polyubiquitination and nuclear degradation.(79) Interestingly, research showed that Mdm2 enhances transcriptional activity of HPV E2 protein, which is critical for the regulation of th…”
BackgroundPeli1 Modulates the Subcellular Localization and Activity of Mdmx
Li, D., Tavana, O., Sun, S., & Gu, W. (2018) · Cancer Research · doi:10.1158/0008-5472.can-17-3531 · Cited by 22
“p53 mono-ubiquitination mediated by low levels of Mdm2 activity induces p53 nuclear export, providing an example of ubiquitination-mediated nuclear cytoplasmic shuttling (14).”
BackgroundInfluentialSelf-citationBustamante, H. A., Cereceda, K., González, A., Valenzuela, G., Cheuquemilla, Y., Hernández, S., Arias‐Muñoz, E., Cerda‐Troncoso, C., Bandau, S., Soza, A., et al. (2020) · Cells · doi:10.3390/cells9030777 · Cited by 21
Soluble Guanylyl Cyclase α1 and p53 Cytoplasmic Sequestration and Down-Regulation in Prostate Cancer
Cai, C., Hsieh, C.-L., Gao, S., Kannan, A., Bhansali, M., Govardhan, K., Dutta, R. N., & Shemshedini, L. (2011) · Molecular Endocrinology · doi:10.1210/me.2010-0394 · Cited by 30
Wang, Z., Suzuki, H. R., Kobayashi, M., et al. (2007) · Biochemistry · doi:10.1021/bi0618060 · Cited by 22
Ma, X., Wu, K., Xu, A., Jiao, P., Li, H., & Lihua, X. (2020) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2020.103513 · Cited by 21
Zhang, L., Hou, N., Chen, B., Kan, C., Han, F., Zhang, J., & Sun, X. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.908772 · Cited by 24
“Overexpression of MDM2 leads to inactive p53, resulting in the generation of infinitely replicating cells (Li et al., 2003).”
BackgroundThe SUMOylation and ubiquitination crosstalk in cancer
Li, K., Xia, Y., He, J., Wang, J., Li, J., Ye, M., & Jin, X. (2023) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-023-05310-z · Cited by 25
“On the one hand, MDM2 degrades p53 through polyubiqui-tination, and on the other hand, low-level MDM2 can also catalyze monoubiquitination of p53, resulting in a nuclear output of p53 (Li et al. 2003).”
Background
Metadata
- Authors
- Li, M., Brooks, C. L., Wu-Baer, F., Chen, D., Baer, R., & Gu, W.
- Affiliations
- Columbia University (US)
- Corresponding author
- Gu, Wei
- Venue
- Science
- Published
- 2003-12-12
- Volume
- 302
- Issue
- 5652
- Pages
- 1972-1975
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2050745715
- Cited by
- 804
- References
- 30
- Citations by year
- 2026: 6 · 2025: 15 · 2024: 21 · 2023: 21 · 2022: 24 · 2021: 25 · 2020: 28 · 2019: 22 · 2018: 22 · 2017: 24 · 2016: 32 · 2015: 34 · 2014: 45 · 2013: 37 · 2012: 38
- FWCI
- 19.73
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Heat shock proteins research
- Keywords
- p53, MDM2, monoubiquitination, polyubiquitination, ubiquitination, p53 degradation, tumor suppressor regulation
- MeSH terms
- Animals, Cell Nucleus, Cells, Cultured, Cytoplasm, Humans, Mutation, Nuclear Proteins, Proto-Oncogene Proteins, Recombinant Fusion Proteins, Transfection, Tumor Suppressor Protein p53, Mice, Knockout, Protein Transport, Active Transport, Cell Nucleus, Ubiquitin, Cell Line, Tumor, Mice, Proto-Oncogene Proteins c-mdm2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.